发明名称 USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE
摘要 PROBLEM TO BE SOLVED: To provide corticosteroid effective on the therapy in the treatment of diseases of airway passages and lungs such as asthma, and exhibiting low bioavailability and low systemic side effects when administered by intra-nasally or oral inhalation. SOLUTION: The aerosolized medicament for the once-a-day treatment of asthma by oral inhalation for initial treatment or maintenance treatment in the substantial absence of systemic absorption into the bloodstream of mometasone furoate contains the mometasone furoate. COPYRIGHT: (C)2008,JPO&INPIT
申请公布号 JP2008031184(A) 申请公布日期 2008.02.14
申请号 JP20070273211 申请日期 2007.10.19
申请人 SCHERING CORP 发明人 SEQUEIRA JOEL A;CUSS FRANCIS M;NOLOP KEITH B;CHAUDRY IMTIAZ A;NAGABHUSHAN NAGAMANI;PATRICK JAMES E;CAYEN MITCHELL
分类号 A61K9/12;A61K31/573;A61K9/00;A61K9/10;A61K9/14;A61K9/72;A61K31/00;A61K31/57;A61K31/58;A61K47/06;A61P11/00;A61P11/02;A61P11/06;A61P27/00;A61P27/16;A61P37/00;A61P37/04;A61P37/08;C07J17/00 主分类号 A61K9/12
代理机构 代理人
主权项
地址